GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Tianyao Pharmaceutical Co Ltd (SHSE:600488) » Definitions » Policy Acquisition Expense

Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Policy Acquisition Expense


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Tianyao Pharmaceutical Co Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Business Description

Traded in Other Exchanges
N/A
Address
No. 109 Bawei Road, Hedong District, Tianjin, Tianjin, CHN, 300171
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
Executives
Wang Chun Li senior management
Wang Li Feng Directors, senior managers
Wang Shu Li senior management
Zheng Xiu Chun senior management
Liu Xin Directors, senior managers
Wu Sheng senior management
Di Luan Director